Nicole Danielle Pecora, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microbiological Techniques | 2 | 2020 | 98 | 1.370 |
Why?
|
beta-Lactamases | 4 | 2022 | 304 | 1.330 |
Why?
|
Enterobacter cloacae | 2 | 2019 | 22 | 1.150 |
Why?
|
Carbapenems | 2 | 2019 | 123 | 1.070 |
Why?
|
Clinical Laboratory Techniques | 2 | 2021 | 749 | 1.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 393 | 0.650 |
Why?
|
Microspheres | 1 | 2021 | 785 | 0.590 |
Why?
|
Escherichia coli Infections | 1 | 2021 | 524 | 0.570 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 612 | 0.510 |
Why?
|
Escherichia coli Proteins | 2 | 2021 | 1066 | 0.510 |
Why?
|
Cross Infection | 2 | 2022 | 1434 | 0.500 |
Why?
|
beta-Lactam Resistance | 1 | 2015 | 74 | 0.490 |
Why?
|
Bacterial Proteins | 5 | 2022 | 3822 | 0.460 |
Why?
|
Toll-Like Receptor 2 | 4 | 2010 | 348 | 0.460 |
Why?
|
Enterobacteriaceae Infections | 1 | 2015 | 192 | 0.440 |
Why?
|
Klebsiella pneumoniae | 1 | 2015 | 255 | 0.440 |
Why?
|
Lipoproteins | 5 | 2010 | 882 | 0.420 |
Why?
|
Escherichia coli | 3 | 2021 | 4223 | 0.380 |
Why?
|
Pandemics | 2 | 2021 | 8621 | 0.370 |
Why?
|
Plasmids | 3 | 2022 | 2277 | 0.360 |
Why?
|
Mycobacterium tuberculosis | 6 | 2011 | 1905 | 0.330 |
Why?
|
Genomics | 2 | 2021 | 5790 | 0.300 |
Why?
|
Mycobacterium bovis | 1 | 2008 | 147 | 0.300 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2010 | 1446 | 0.290 |
Why?
|
Antigen-Presenting Cells | 2 | 2008 | 967 | 0.270 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 410 | 0.260 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7400 | 0.230 |
Why?
|
Metapneumovirus | 1 | 2024 | 28 | 0.230 |
Why?
|
Paramyxoviridae Infections | 1 | 2024 | 57 | 0.230 |
Why?
|
Dendritic Cells | 3 | 2010 | 2730 | 0.220 |
Why?
|
Enterobacter | 1 | 2022 | 46 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.200 |
Why?
|
Nucleocapsid | 1 | 2022 | 63 | 0.200 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3145 | 0.200 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1933 | 0.190 |
Why?
|
Fluoroimmunoassay | 1 | 2021 | 30 | 0.190 |
Why?
|
Adenovirus Infections, Human | 1 | 2021 | 73 | 0.180 |
Why?
|
Viruses | 1 | 2024 | 376 | 0.170 |
Why?
|
Adenoviruses, Human | 1 | 2021 | 255 | 0.170 |
Why?
|
Immunoglobulin G | 2 | 2022 | 4546 | 0.170 |
Why?
|
Multilocus Sequence Typing | 1 | 2019 | 100 | 0.160 |
Why?
|
Conjugation, Genetic | 1 | 2019 | 121 | 0.160 |
Why?
|
Gene Transfer, Horizontal | 1 | 2019 | 144 | 0.150 |
Why?
|
Laboratories | 1 | 2021 | 461 | 0.150 |
Why?
|
Virus Diseases | 1 | 2024 | 721 | 0.150 |
Why?
|
Genome, Viral | 1 | 2021 | 658 | 0.150 |
Why?
|
Mycoses | 1 | 2020 | 387 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2022 | 1529 | 0.140 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14656 | 0.140 |
Why?
|
Metagenomics | 1 | 2020 | 457 | 0.140 |
Why?
|
Immunity, Humoral | 1 | 2020 | 604 | 0.130 |
Why?
|
Microbial Sensitivity Tests | 1 | 2022 | 1952 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1001 | 0.130 |
Why?
|
Bacillus cereus | 1 | 2015 | 36 | 0.130 |
Why?
|
Tuberculosis | 1 | 2008 | 2003 | 0.130 |
Why?
|
Meningoencephalitis | 1 | 2015 | 83 | 0.120 |
Why?
|
Boston | 2 | 2019 | 9282 | 0.120 |
Why?
|
Acylation | 3 | 2010 | 98 | 0.110 |
Why?
|
Toll-Like Receptor 1 | 2 | 2010 | 49 | 0.110 |
Why?
|
Kinetics | 1 | 2021 | 6378 | 0.110 |
Why?
|
Genes, Bacterial | 2 | 2015 | 1070 | 0.110 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 343 | 0.110 |
Why?
|
Influenza, Human | 1 | 2024 | 1532 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1402 | 0.100 |
Why?
|
Humans | 21 | 2024 | 760261 | 0.100 |
Why?
|
Phosphoproteins | 1 | 2021 | 2441 | 0.100 |
Why?
|
Integrin alpha5beta1 | 1 | 2011 | 37 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1054 | 0.100 |
Why?
|
DNA, Bacterial | 1 | 2015 | 1455 | 0.090 |
Why?
|
Genome, Bacterial | 1 | 2015 | 770 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5498 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 857 | 0.090 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 17628 | 0.090 |
Why?
|
Glycolipids | 1 | 2010 | 204 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4717 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4355 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3618 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15766 | 0.070 |
Why?
|
Genotype | 2 | 2021 | 12959 | 0.060 |
Why?
|
Peptidoglycan | 1 | 2007 | 250 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1254 | 0.060 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2007 | 407 | 0.060 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2010 | 832 | 0.060 |
Why?
|
Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2002 | 5 | 0.050 |
Why?
|
Glycosylation | 1 | 2006 | 1097 | 0.050 |
Why?
|
Proteus mirabilis | 1 | 2002 | 25 | 0.050 |
Why?
|
Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2002 | 23 | 0.050 |
Why?
|
Down-Regulation | 1 | 2010 | 2918 | 0.050 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2024 | 167 | 0.050 |
Why?
|
Macrophages | 2 | 2009 | 5745 | 0.050 |
Why?
|
Rhinovirus | 1 | 2024 | 202 | 0.050 |
Why?
|
Cell Line | 4 | 2010 | 15626 | 0.050 |
Why?
|
Hospitals | 1 | 2015 | 3929 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2002 | 575 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2009 | 22025 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2424 | 0.050 |
Why?
|
Genetic Variation | 1 | 2015 | 6540 | 0.040 |
Why?
|
Adenoviridae | 1 | 2024 | 1084 | 0.040 |
Why?
|
Ligands | 1 | 2006 | 3277 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 394 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13456 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2006 | 1589 | 0.040 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2002 | 1129 | 0.030 |
Why?
|
United States | 2 | 2021 | 72363 | 0.030 |
Why?
|
Specimen Handling | 1 | 2021 | 708 | 0.030 |
Why?
|
Female | 7 | 2024 | 391011 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58947 | 0.030 |
Why?
|
Immunologic Memory | 2 | 2011 | 1354 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2006 | 3046 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2775 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6850 | 0.030 |
Why?
|
Mice | 3 | 2009 | 81216 | 0.030 |
Why?
|
Integrin alpha5 | 1 | 2011 | 20 | 0.030 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2011 | 87 | 0.020 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2011 | 119 | 0.020 |
Why?
|
Cytokines | 1 | 2006 | 7345 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2008 | 11480 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 220175 | 0.020 |
Why?
|
Toll-Like Receptor 6 | 1 | 2009 | 29 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 2010 | 282 | 0.020 |
Why?
|
Protein Binding | 2 | 2011 | 9336 | 0.020 |
Why?
|
Aged | 1 | 2021 | 168995 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 617 | 0.020 |
Why?
|
Male | 3 | 2021 | 359413 | 0.020 |
Why?
|
Periplasmic Proteins | 1 | 2007 | 25 | 0.020 |
Why?
|
Animals | 3 | 2009 | 167940 | 0.020 |
Why?
|
Oligopeptides | 1 | 2011 | 1188 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2007 | 389 | 0.020 |
Why?
|
Signal Transduction | 2 | 2011 | 23363 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2010 | 18968 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17159 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 80301 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2011 | 1977 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2009 | 1155 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 3800 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2011 | 3160 | 0.010 |
Why?
|
Artificial Gene Fusion | 1 | 2002 | 56 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2214 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4127 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2011 | 2536 | 0.010 |
Why?
|
Cytoplasm | 1 | 2007 | 1518 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2056 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 522 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26168 | 0.010 |
Why?
|
Monocytes | 1 | 2010 | 2574 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8314 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2007 | 1120 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4357 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5429 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3606 | 0.010 |
Why?
|
Cell Division | 1 | 2007 | 4462 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2002 | 814 | 0.010 |
Why?
|
Adult | 3 | 2024 | 219847 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3735 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12447 | 0.010 |
Why?
|
Mutation | 2 | 2010 | 29950 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11902 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2007 | 7854 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 58673 | 0.000 |
Why?
|